期刊
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
卷 155, 期 6, 页码 2492-2501出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jtcvs.2017.12.127
关键词
metabolic syndrome; chronic coronary ischemia; glycogen synthase kinase 3B; oxidative stress; collagen
资金
- National Heart, Lung, and Blood Institute [RO1HL128831, RO1 HL46716]
- NIH [T32 GM065085]
- National Institutes of Health/National Institute of General Medical Sciences [2T32 GM065085]
- American Heart Association [GRNT20460376]
- National Institute of General Medical Sciences [U54GM115677]
Objectives: Glycogen synthase kinase 3 beta (GSK-3 beta) inhibition has been reported to increase microvascular density and improve myocardial blood flow in a porcine model of chronic myocardial ischemia and metabolic syndrome. Inhibition of GSK-3 beta can also be cardioprotective by modulating fibrosis signaling and mitochondrial-induced apoptosis. We hypothesized GSK-3 beta inhibition would have a beneficial effect on myocardial fibrosis and oxidative stress in a porcine model of chronic myocardial ischemia and metabolic syndrome. Methods: Pigs were fed a high fat diet for 4 weeks followed by placement of an ameroid constrictor to the left circumflex coronary artery. Three weeks later animals received either no drug or a GSK-3 beta inhibitor. The diets and placebo/GSK-3 beta inhibition were continued for an additional 5 weeks, the pigs were then euthanized, and the myocardial tissue was harvested. Collagen expression was analyzed via Picrosirius staining. Oxidative stress was analyzed via Oxyblot analysis. Protein expression was analyzed via Western blot. Results: GSK-3 beta inhibition was associated with decreased collagen expression and oxidative stress in the ischemic and nonischemic myocardial tissue compared with control. There was a decrease in profibrotic proteins transforming growth factor-beta, p-SMAD2/3, and matrix metalloproteinase-9, and in proapoptotic and oxidative stress proteins, apoptosis inducing factor, the cleaved caspase 3/caspase 3 protein ratio and phosphorylated myeloid cell leukemia sequence-1 in the GSK-3 beta inhibited group compared with the control. Conclusions: In the setting of metabolic syndrome and chronic myocardial ischemia, inhibition of GSK-3 beta decreases collagen formation and oxidative stress in myocardial tissue. GSK-3 beta inhibition might be having this beneficial effect by downregulating transforming growth factor-beta/SMAD2/3 signaling and decreasing mitochondrial induced cellular stress.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据